According to Johns Hopkins University, the overall death toll from coronavirus stood at 1,881,926 globally, while the total cases mounted to 87,150,958, as of Thursday morning.
The US is the worst-hit country, with the world’s highest number of cases and deaths at 21,292,109 and 360,999, respectively, according to the university data.
Also read: Over 86 million infected with COVID globally
India comes second in terms of COVID cases, at 10,374,932, while the country’s death toll soared to 150,114 this morning, according to the Health Ministry.
Brazil registered 1,242 deaths from COVID-19 in the past 24 hours, bringing the national death toll to 198,974, the Ministry of Health announced on Wednesday.
The country confirmed 63,430 new cases, taking the nationwide count to 7,873,830, it added.
Also read: Global Covid-19 cases surpass 80.7 million amid rising infections
Brazil is currently seeing a second wave of COVID-19 outbreaks, with a significant increase in cases since December that has pushed the public healthcare system to the brink of collapse in several regions.
Situation in Bangladesh
COVID has claimed 17 more lives and infected 978 more people in 24 hours across the country until Wednesday morning.
Also read: Covid-19 claims 17 more lives, 978 new infections recorded in Bangladesh
The total number of deaths rose to 7,687 since the first cases were reported in the country on March 8.
With the new infections, the country’s caseload stood at 518,898, said the Directorate General of Health Services (DGHS).
The country’s infection number reached the 5,00000-mark on December 20. The first death was reported on March 18 and the death toll exceeded 7,000 on December 12.
Also read: Covid-19: Globe Biotech gets nod to manufacture vaccine for clinical trial
Bangladeshi pharmaceutical company Globe Biotech has already got an approval from the Directorate General of Drug Administration (DGDA) for manufacturing COVID vaccine for clinical trial.
Dr Mohammad Mohiuddin, Manager of Globe Biotech Limited (quality operation), said the approval came on December 28.
After completing the trial, Globe Biotech would start supplying vaccine following protocols, he added.
Also read: Global Covid-19 updates: Total cases soar to 78.6 million